Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
T-817MA by FUJIFILM Toyama Chemical for Alzheimer's Disease: Likelihood of Approval
T-817MA is under clinical development by FUJIFILM Toyama Chemical and currently in Phase II for Alzheimer's Disease. According to GlobalData,...